Maxzimaa Pharmaceuticals Private Limited - Due diligence report

A 360° intelligence report on Maxzimaa Pharmaceuticals Private Limited: trust score, financial health, credit view, compliance, directors, g…

2014-12-30 Azadpur, Delhi Active Unlisted Active Compliant
Share
Connect MCP
MP Maxzimaa Pharmaceuticals Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Maxzimaa Pharmaceuticals Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
76/100
Trust Score
Low Risk

Maxzimaa Pharmaceuticals Private Limited is assessed as Low Risk with a Trust Score of 76/100. Maxzimaa Pharmaceuticals Private Limited is an active private limited indian non-government company incorporated in 2014, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 10 Aug 2026 from the latest processed filings. Maxzimaa Pharmaceuticals Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
76/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
70/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • Profitable - internal accruals available.

Charges position: 1 open (45.00 Lakh) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Others1 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
SUCHETA DHAWAN 01234567 Director 01/04/2018 6 yrs Approved
DHIRAJ JOSHI 01234567 Director 01/04/2018 6 yrs Approved
LOVPREET MOTI 01234567 Director 01/04/2018 6 yrs Approved
RACHANA KHATRI 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • RACHANA KHATRI has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 1 transfer(s)

Promoters hold a minority stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 70
Growth signals & trust indicators
Latest year revenue grew 1.42.
Profit expanded 2.1x year-on-year.
Asset base grew 24% - capacity expansion.
Net margin improved to 0.86.
Operating for 11+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Negative net worth.
1 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence84/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment62/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 45.00 Lakh already registered.
  • Compliance record supports lending.
Investor view64/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 13 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
28 Mar 2025
Charge created
Others - 45.00 Lakh
19 Nov 2018
Director ceased
RACHANA KHATRI
18 Oct 2018
Director appointed
RACHANA KHATRI (Director)
31 Mar 2018
Share transfer (FY 2018)
7500.00000000 shares to Dhiraj Joshi
16 Jun 2016
Securities allotted
240000 Equity Shares - 24.00 Lakh raised
20 Jan 2015
Director appointed
SUCHETA DHAWAN (Director)
Director appointed
DHIRAJ JOSHI (Director)
Director appointed
LOVPREET MOTI (Director)
Director ceased
SHWETA PATHAK
Director ceased
PRABHU JYOT SINGH
30 Dec 2014
Incorporated
Registered with Roc Delhi
10

Key Observations

Auto-generated from the data above
Revenue declined 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Compliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a minority stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Rakhuva Pumps Private Limited U74999MH2017PTC301877 Nagpur, Maharashtra, India
Cronimet India Metals Private Limited U51420MH2000PTC125841 Mumbai, Maharashtra, India
Organic Green Foods Limited U15499WB2002PLC094218 Kolkata, West Bengal, India
Timios U15400KA2016PTC086485 Hoskote, Karnataka, India
Tridev Minerals Private Limited U51228DL2012PTC246284 Delhi, Delhi, India
Onato U15412UP2021PTC142782 Lucknow, Uttar Pradesh, India
Maxkem Healthcare Private Limited U24229UP2019PTC123274 Agra, Uttar Pradesh, India
Sanlex Business Solution Private Limited U74999TN2019PTC128352 Chennai, Tamil Nadu, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Maxzimaa Pharmaceuticals Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Maxzimaa Pharmaceuticals Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 70/100, margin trends, ownership structure and peer set for Maxzimaa Pharmaceuticals Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 76/100, distress signals and MSME payment-delay disclosures - know whether Maxzimaa Pharmaceuticals Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Maxzimaa Pharmaceuticals Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Maxzimaa Pharmaceuticals Private Limited an active company?

Maxzimaa Pharmaceuticals Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Maxzimaa Pharmaceuticals Private Limited financially healthy?

Maxzimaa Pharmaceuticals Private Limited has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Maxzimaa Pharmaceuticals Private Limited?

Its overall Trust Score is 76/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Maxzimaa Pharmaceuticals Private Limited?

Promoters hold a minority stake - exact percentages are in the full report. 4 active director(s) are on record.

Does Maxzimaa Pharmaceuticals Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Maxzimaa Pharmaceuticals Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Maxzimaa Pharmaceuticals Private Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.